By Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), New Delhi. The potential of the Indian medical devices industry is immense. With the implementation of enabling measures such as streamlining regulations, achieving self-reliance in domestic production and global competitiveness is very much within our
MTaI held its first Fraternity Meeting of FY-2024-25 which was graced by Secretary, DOP The event was also graced by the Deputy Drugs Controller, CEOs & MDs of more than 20+ research and innovation-based MedTech Companies and Industry stalwarts Medical Technology Association of India (MTaI),
Abrocitinib is the first-of-its-kind oral advanced systemic treatment for adults with moderate-to-severe atopic dermatitis, to be made available in India. Abrocitinib provides rapid itch relief, sustained control of the disease and improved quality of life. Pfizer has received marketing authorization for abrocitinib in adults
The Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with a large footprint in manufacturing and training in India, today hosted a high–level meeting with international delegates, government stakeholders, and MedTech industry captains at Shangri-La, New Delhi. The event was
The first international sale of the SSi Mantra was delivered to Dubai, United Arab Emirates Additional International Sales Expected SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of the “SSi Mantra,” a versatile and cost-effective surgical robotic system, today announced that it
Scheduled to take place on September 1-2 at the prestigious Jio World Convention Centre in Mumbai. Expected attendance of approximately 1,000 industry professionals from 40 countries Agenda features a series of sessions that delve into digital solutions for various healthcare specialties, including Cardiology, Gynaecology,
Sickle-cell anaemia (SCA), a genetic blood disorder, is a public health challenge as India is estimated to have the second-highest burden of the disease, with around 1.8 crore people with sickle cell traits and 14 lakhs with sickle cell disease. Sickle cell Anemia often causes
MedTech Policy Conclave 2023, organized after the introduction of the National Medical Devices Policy, gets a robust response from all stakeholders who underpinned the major pain points and the way forward MedTech Policy Mahotsava Conclave 2023, organized by Medgate Today, witnessed a remarkable turnout
MedTech Policy Conclave 2023, organized after the introduction of the National Medical Devices Policy, gets a robust response from all stakeholders who underpinned the major pain points and the way forward MedTech Policy Mahotsava Conclave 2023, organized by Medgate Today, witnessed a remarkable
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate
